Synaptive partners with Nova Scotia Health Authority and Government of Canada to Advance Patient Care

Français

Partnership led by the Atlantic Canada Opportunities Agency to support research and development of miniature device for cardiovascular and neuro surgeries

HALIFAX, NS (February 10, 2017) — Synaptive Medical Inc. has partnered with Nova Scotia Health Authority (NSHA), the Government of Canada’s Atlantic Canada Opportunities Agency (ACOA), and Conavi Medical to support and create a probe prototype for imaging and tissue-cutting in neuro and cardiovascular surgeries.

The miniature endoscope uses ultrasound for both imaging and precision cutting during surgery. Small enough for surgeons to insert into the brain through a small hole, it will assist in the diagnosis and treatment of serious conditions such as blood clots and brain tumors. It also has application in minimally invasive cardiac procedures.

The Government of Canada is making a $2.8M investment over five years in the NSHA to develop the miniature endoscope prototype, which is expected to improve patient survival rates. The project will also create several highly-skilled positions in Nova Scotia’s life sciences sector, including training and job development placements for graduate students.

The federal funding was announced today by Darrell Samson, Member of Parliament for Sackville-Preston-Chezzetcook, on behalf of the Honourable Navdeep Bains, Minister of Innovation, Science and Economic Development and Minister responsible for ACOA.

“The work of the Nova Scotia Health Authority exemplifies Canada’s readiness to participate in the global innovation race, competing with countries around the world for the most talented people, the newest technologies and the fastest-growing companies,” said the Honourable Navdeep Bains. “That is why the Government of Canada is committed to supporting projects such as this, which enhance Atlantic Canada’s ability to compete in the global marketplace.”

“Nova Scotia’s life sciences sector is thriving due to our R&D capabilities and highly trained individuals,” said Darrel Samson. “It is innovation like this that provides high quality jobs for our educated workforce, helping to attract and retain talent in the region. The NSHA is setting the bar internationally for excellence in hi-resolution ultrasound technology, creating economic spinoffs right here at home.”

“As a medical device and technology company based in Toronto, Synaptive welcomes opportunities to work with industry and research partners across Canada,” said Cameron Piron, Synaptive’s president and co-founder. “Partnering with the Nova Scotia Health Authority and Conavi Medical presents an exciting opportunity to leverage our expertise in surgery, ultrasound and medical imaging while developing a product that stands to benefit patients in Canada and around the world.”

Read the full story here.